Human Anaplasmosis

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Human Anaplasmosis trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT07312474

Epidemiological, Clinical and Biological Characteristics of Human Anaplasmosis Cases in Alsace

Anaplasmosis is a bacterial infection caused by the intracellular bacterium Anaplasma phagocytophilum and transmitted by ticks. This bacterium is present in app…

France100 participantsStarted 2024-10-02

All recent trials (3 shown)

WithdrawnNot Applicable

NCT03932448

Fever After Tick Bite Study

The proposed study is a collaboration between Microbiology, SU/Sahlgrenska and the Infectious Diseases clinic at SU/Östra as well as several Infectious Diseases…

Sweden0Started 2019-05-15

Treatment: The proposed study is not interventional.

UnknownNot Applicable

NCT01013636

Human Anaplasmosis in Eastern France

Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever, cytopenia and hepatitis.This infection was initially described in Uni…

France300 participantsStarted 2009-11

Treatment: Blood sampling